First report of metabolic complete response in hepatic sarcomatoid carcinoma achieved with carbon-ion radiotherapy
Related Experiment Video
Updated: Sep 16, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Ryu Takakura1, Yoshiyuki Ota1, Yuki Yamazaki1
1Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan.
Abstract:
Hepatic sarcomatoid carcinoma (HSC) is a rare and highly aggressive subtype of primary liver cancer with no established treatment for unresectable cases. We report the case of a 71-year-old woman with unresectable HSC who achieved complete remission following carbon-ion radiotherapy. The patient exhibited a favorable response to primary tumor and lymph node metastases, with no recurrence observed after 17 months. This case highlights the potential efficacy of heavy-ion therapy as a promising alternative for managing HSC.
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017